​Fischer Medical Ventures Highlights Strategic Partnership as NYB.AI Showcased at NVIDIA GTC Taiwan 2026
Fischer Medical Ventures Limited (FMVL) today announced that its strategic partner, Nanyang Biologics, has achieved a significant international milestone with its AI-powered molecular research platform, NYB.AI, being featured in the opening showcase at NVIDIA GTC Taiwan 2026, ahead of the keynote address by NVIDIA Founder and CEO Jensen Huang. The recognition places NYB.AI among a select group of innovators from NVIDIA's global Inception ecosystem driving advancements in artificial intelligence, computational biology and next-generation scientific research. For Fischer Medical Ventures, the recognition reinforces the strength of its strategic partnership with Nanyang...
ONLY AVAILABLE IN PAID PLANS
Published by: newsdeck_in
Read full article here: https://newsdeck.in/2026/07/08/fischer-medical-ventures-highlights-strategic-partnership-as-nyb-ai-showcased-at-nvidia-gtc-taiwan-2026/
- Vijay Raman
- Top
- Health
- India
